| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 972.71M | 924.60M | 725.10M | 534.22M | 461.98M |
| Gross Profit | 170.65M | 161.88M | 146.97M | 123.61M | 106.22M |
| EBITDA | 126.12M | 129.42M | 120.88M | 120.07M | 87.08M |
| Net Income | 66.80M | 65.32M | 74.43M | 64.11M | 55.47M |
Balance Sheet | |||||
| Total Assets | 1.97B | 1.72B | 1.62B | 1.44B | 1.32B |
| Cash, Cash Equivalents and Short-Term Investments | 405.94M | 403.36M | 485.22M | 355.91M | 302.64M |
| Total Debt | 105.92M | 109.21M | 119.32M | 293.47M | 301.82M |
| Total Liabilities | 1.08B | 879.87M | 805.74M | 672.57M | 762.13M |
| Stockholders Equity | 854.54M | 824.88M | 796.03M | 747.03M | 549.15M |
Cash Flow | |||||
| Free Cash Flow | 50.13M | 2.14M | 85.79M | -48.71M | 9.25M |
| Operating Cash Flow | 69.52M | 41.60M | 134.82M | 8.77M | 70.27M |
| Investing Cash Flow | -1.23M | -39.61M | -63.97M | -56.59M | -64.39M |
| Financing Cash Flow | -29.13M | -44.26M | -32.35M | 92.68M | 8.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$121.90M | 6.11 | 7.97% | 6.85% | 5.23% | 2.27% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | HK$133.48M | 4.08 | 4.90% | ― | -2.47% | -1.55% | |
59 Neutral | HK$2.77B | 22.75 | -12.90% | 4.41% | -7.01% | ― | |
55 Neutral | HK$279.04M | -3.51 | -9.16% | 15.45% | 1.07% | -1080.00% | |
49 Neutral | HK$215.11M | 1.31 | 3147.50% | ― | -4.36% | 1481.82% | |
48 Neutral | HK$99.60M | -0.38 | -31.59% | ― | -4.58% | 1.46% |